Etomethazene: Difference between revisions
Content deleted Content added
No edit summary |
No edit summary |
||
| Line 16: | Line 16: | ||
}} |
}} |
||
'''Etomethazene''' ('''5-methyldesnitroetonitazene''', '''5-methyl etodesnitazene''') is a [[benzimidazole]] derivative with [[opioid]] effects which has been sold as a [[designer drug]] over the internet since early 2022. It is an analogue of [[etonitazene]] where the nitro (NO<sub>2</sub>) group has been replaced by a methyl (CH<sub>3</sub>) group. While formal studies into its pharmacology have yet to be carried out, it showed far less potency than etonitazene itself. |
'''Etomethazene''' ('''5-methyldesnitroetonitazene''', '''5-methyl etodesnitazene''', '''Eto''') is a [[benzimidazole]] derivative with [[opioid]] effects which has been sold as a [[designer drug]] over the internet since early 2022. It is an analogue of [[etonitazene]] where the nitro (NO<sub>2</sub>) group has been replaced by a methyl (CH<sub>3</sub>) group. While formal studies into its pharmacology have yet to be carried out, it showed far less potency than etonitazene itself. |
||
Etomethazene has an analgesic potency around 20 times that of [[morphine]] with a relatively short duration of about 120 min.<ref>{{cite web | title = Early signal alert: Emergence of online mentions of etomethazene | url = https://ndews.org/?wysija-page=1&controller=email&action=view&email_id=347&wysijap=subscriptions | work = National Drug Early Warning System| issue = 91 | date = 1 July 2022 }}</ref><ref>{{cite web | url = https://www.caymanchem.com/product/36767/5-methyl-etodesnitazene-(citrate) | title = 5-methyl Etodesnitazene (citrate) | work = Caymanchem.com }}</ref><ref>[https://www.aklagare.se/globalassets/dokument/narkotikapreparat/e/etometazen2.pdf KLASSIFICERINGSDOKUMENT Narkotika. Etometazen (5-metyletodesnitazen)]</ref> |
Etomethazene has an analgesic potency around 20 times that of [[morphine]] with a relatively short duration of about 120 min.<ref>{{cite web | title = Early signal alert: Emergence of online mentions of etomethazene | url = https://ndews.org/?wysija-page=1&controller=email&action=view&email_id=347&wysijap=subscriptions | work = National Drug Early Warning System| issue = 91 | date = 1 July 2022 }}</ref><ref>{{cite web | url = https://www.caymanchem.com/product/36767/5-methyl-etodesnitazene-(citrate) | title = 5-methyl Etodesnitazene (citrate) | work = Caymanchem.com }}</ref><ref>[https://www.aklagare.se/globalassets/dokument/narkotikapreparat/e/etometazen2.pdf KLASSIFICERINGSDOKUMENT Narkotika. Etometazen (5-metyletodesnitazen)]</ref> |
||
Revision as of 10:38, 1 May 2024
 | |
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C23H31N3O |
| Molar mass | 365.521 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Etomethazene (5-methyldesnitroetonitazene, 5-methyl etodesnitazene, Eto) is a benzimidazole derivative with opioid effects which has been sold as a designer drug over the internet since early 2022. It is an analogue of etonitazene where the nitro (NO2) group has been replaced by a methyl (CH3) group. While formal studies into its pharmacology have yet to be carried out, it showed far less potency than etonitazene itself. Etomethazene has an analgesic potency around 20 times that of morphine with a relatively short duration of about 120 min.[1][2][3]
See also
References
- ^ "Early signal alert: Emergence of online mentions of etomethazene". National Drug Early Warning System. 1 July 2022.
- ^ "5-methyl Etodesnitazene (citrate)". Caymanchem.com.
- ^ KLASSIFICERINGSDOKUMENT Narkotika. Etometazen (5-metyletodesnitazen)
 | This analgesic-related article is a stub. You can help Wikipedia by expanding it. |